TALPHERA, INC. (TLPH) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2023-12-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2023-12-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2023-12-31..
Borrowing debt
Overview →Financial period ending 2023-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2023-12-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2023-12-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2023-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 20.39M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $20.39M | (m) |
| 2023-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $23.26M | (m) |
| 2023-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $17.73M | (m) |
| 2023-03-31 | (m) | (m) | $3.32M | (m) | (m) | (m) | $26.29M | (m) |
| 2022-12-31 | (m) | (m) | $5.76M | $0.00 | (m) | (m) | $47.49M | (m) |
| 2022-09-30 | (m) | (m) | $7.89M | $0.00 | (m) | (m) | $48.31M | (m) |
| 2022-06-30 | (m) | (m) | $9.89M | $0.00 | (m) | (m) | $56.13M | (m) |
| 2022-03-31 | (m) | (m) | $8.81M | $3.04M | (m) | (m) | $71.97M | (m) |
| 2021-12-31 | (m) | (m) | $8.80M | $5.01M | (m) | (m) | $77.89M | (m) |
| 2021-09-30 | (m) | (m) | $8.78M | $6.95M | (m) | (m) | $72.26M | (m) |
| 2021-06-30 | (m) | (m) | $8.76M | $9.37M | (m) | (m) | $79.59M | (m) |
| 2021-03-31 | (m) | (m) | $8.75M | $11.27M | (m) | (m) | $87.35M | (m) |
| 2020-12-31 | (m) | (m) | $8.73M | $13.14M | (m) | (m) | $66.30M | (m) |
| 2020-09-30 | (m) | (m) | $8.72M | $14.99M | (m) | (m) | $66.18M | (m) |
| 2020-06-30 | (m) | (m) | $8.71M | $17.32M | (m) | (m) | $67.40M | (m) |
| 2020-03-31 | (m) | (m) | $6.61M | $19.13M | (m) | (m) | $77.34M | (m) |
| 2019-12-31 | (m) | (m) | $4.63M | $20.52M | (m) | (m) | $91.36M | (m) |
| 2019-09-30 | (m) | (m) | $2.08M | $21.92M | (m) | (m) | $104.98M | (m) |
| 2019-06-30 | (m) | (m) | (m) | $23.77M | (m) | (m) | $115.11M | (m) |
| 2019-03-31 | (m) | (m) | $10.03M | (m) | (m) | (m) | $113.44M | (m) |
| 2018-12-31 | (m) | (m) | $8.61M | $3.38M | (m) | (m) | $120.53M | (m) |
| 2018-09-30 | (m) | (m) | $8.37M | $5.50M | (m) | (m) | $77.74M | (m) |
| 2018-06-30 | (m) | (m) | $8.14M | $7.54M | (m) | (m) | $64.62M | (m) |
| 2018-03-31 | (m) | (m) | $7.92M | $9.49M | (m) | (m) | $65.81M | (m) |
| 2017-12-31 | (m) | (m) | $7.73M | $11.37M | (m) | (m) | $75.55M | (m) |
| 2017-09-30 | (m) | (m) | $9.25M | $13.15M | (m) | (m) | $82.74M | (m) |
| 2017-06-30 | (m) | (m) | $7.13M | $14.89M | (m) | (m) | $78.19M | (m) |
| 2017-03-31 | (m) | (m) | $5.06M | $16.58M | (m) | (m) | $88.44M | (m) |
| 2016-12-31 | (m) | (m) | $2.91M | $18.64M | (m) | (m) | $99.99M | (m) |
| 2016-09-30 | (m) | (m) | $9.18M | $12.14M | (m) | (m) | $106.00M | (m) |
| 2016-06-30 | (m) | (m) | $13.94M | $7.41M | (m) | (m) | $113.57M | (m) |
| 2016-03-31 | (m) | (m) | $9.19M | $11.94M | (m) | (m) | $121.22M | (m) |
| 2015-12-31 | (m) | (m) | $4.54M | $16.38M | (m) | (m) | $127.78M | (m) |
| 2015-09-30 | (m) | (m) | (m) | $20.72M | (m) | (m) | $131.56M | (m) |
| 2015-06-30 | (m) | (m) | $9.51M | $13.62M | (m) | (m) | $63.56M | (m) |
| 2015-03-31 | (m) | (m) | $9.29M | $15.85M | (m) | (m) | $75.59M | (m) |
| 2014-12-31 | (m) | (m) | $6.86M | $18.05M | (m) | (m) | $86.45M | (m) |
| 2014-09-30 | (m) | (m) | $4.51M | $20.36M | (m) | (m) | $96.44M | (m) |
| 2014-06-30 | (m) | (m) | $2.21M | $22.43M | (m) | (m) | $100.37M | (m) |
| 2014-03-31 | (m) | (m) | (m) | $14.49M | (m) | (m) | $100.42M | (m) |
| 2013-12-31 | (m) | (m) | (m) | $14.36M | (m) | (m) | $110.03M | (m) |
| 2013-09-30 | (m) | (m) | $8.13M | $2.38M | (m) | (m) | $80.66M | (m) |
| 2013-06-30 | (m) | (m) | $7.89M | $4.50M | (m) | (m) | $40.80M | (m) |
| 2013-03-31 | (m) | (m) | $7.66M | $6.54M | (m) | (m) | $52.98M | (m) |
| 2012-12-31 | (m) | (m) | $7.44M | $8.53M | (m) | (m) | $64.52M | (m) |
| 2012-09-30 | (m) | (m) | $7.23M | $10.46M | (m) | (m) | $28.15M | (m) |
| 2012-06-30 | (m) | (m) | $7.01M | $12.32M | (m) | (m) | $36.64M | (m) |
| 2012-03-31 | (m) | (m) | $5.68M | $13.50M | (m) | (m) | $33.99M | (m) |
| 2011-12-31 | (m) | (m) | $3.80M | $15.28M | (m) | (m) | $40.84M | (m) |
| 2011-09-30 | (m) | (m) | $681.00K | $8.20M | (m) | (m) | $36.70M | (m) |
| 2011-06-30 | (m) | (m) | (m) | $8.73M | (m) | (m) | $40.99M | (m) |
| 2010-12-31 | (m) | (m) | $5.20M | (m) | (m) | (m) | $6.83M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |